Association between mammographic density and tumor marker-defined breast cancer subtypes: A case-control study

European Journal of Cancer Prevention

Volumn 27, Issue 3, 2018, Pages 239-247

  Shin, Jinyoung ^a,b   Lee, Jeong Eon ^a   Ko, Hyeon Young ^a,b   Nguyen, Tuong Linh ^d   Nam, Seok Jin ^a   Hopper, John Llewelyn ^c,d   Song, Yun Mi ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Seoul National University   (South Korea)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER; ERBB2 PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST CANCER MOLECULAR SUBTYPE; BREAST DENSITY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIGITAL MAMMOGRAPHY; FEMALE; HUMAN; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MAJOR CLINICAL STUDY; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; BIOSYNTHESIS; BREAST TUMOR; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; GENETICS; METABOLISM; PHYSIOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TRENDS;

ADULT; BIOMARKERS, TUMOR; BREAST DENSITY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, MAMMARY;

EID: 85044869964     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000353     Document Type: Article

References (56)

1. Aiello EJ, Buist DS, White E, Porter PL (2005). Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 14:662-668.
2. Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, et al. (2010). Impact of breast density on the presenting features of malignancy. Ann Surg Oncol 17 (Suppl 3):211-218.
3. Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz V, Visscher D, et al. (2013). Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15:R104.
4. Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Buttarelli M, Jacquemier J, et al. (2009). How different are luminal A and basal breast cancers? Int J Cancer 124:1338-1348.
5. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, et al. (2002). The association of breast mitogens with mammographic densities. Br J Cancer 87:876-882.
6. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. (2005). Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808.
7. Byng JW, Yaffe MJ, Jong RA, Shumak RS, Lockwood GA, Tritchler DL, et al. (1998). Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 18:1587-1598.
8. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502.
9. Cho EY, Choi YL, Han JJ, Kim KM, Oh YL (2008). Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathol Int 58:17-25.
10. Conroy SM, Pagano I, Kolonel LN, Maskarinec G (2011). Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study. Cancer Epidemiol 35:448-452.
11. Defilippis RA, Chang H, Dumont N, Rabban JT, Chen YY, Fontenay GV, et al. (2012). CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov 2:826-839.
12. Ding J, Warren R, Girling A, Thompson D, Easton D (2010). Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 16:279-289.
13. Dontu G, El-Ashry D, Wicha MS (2004). Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 15:193-197.
14. Eriksson L, Hall P, Czene K, Dos Santos Silva I, Mccormack V, Bergh J, et al. (2012). Mammographic density and molecular subtypes of breast cancer. Br J Cancer 107:18-23.
15. Ghosh K, Brandt KR, Sellers TA, Reynolds C, Scott CG, Maloney SD, et al. (2008). Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:872-879.
16. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, et al. (2010a). Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 28:2207-2212.
17. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, et al. (2010b). Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst 102:1716-1723.
18. Greendale GA, Huang MH, Ursin G, Ingles S, Stanczyk F, Crandall C, et al. (2007). Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat 105:337-346.
19. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. (2010). American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795.
20. Heusinger K, Jud SM, Haberle L, Hack CC, Fasching PA, Meier-Meitinger M, et al. (2012). Association of mammographic density with the proliferation marker Ki- 67 in a cohort of patients with invasive breast cancer. Breast Cancer Res Treat 135:885-892.
21. Hopper JL, Dite GS (2002). Re: 'Presenting statistical uncertainty in trends and dose-response relations'. Am J Epidemiol 155:977-978. author reply 978-979.
22. Huo CW, Chew GL, Britt KL, Ingman WV, Henderson MA, Hopper JL, et al. (2014). Mammographic density-A review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 144:479-502.
23. Kim BK, Choi YH, Nguyen TL, Nam SJ, Lee JE, Hopper JL, et al. (2015). Mammographic density and risk of breast cancer in Korean women. Eur J Cancer Prev 24:422-429.
24. Kotsuma Y, Tamaki Y, Nishimura T, Tsubai M, Ueda S, Shimazu K, et al. (2008). Quantitative assessment of mammographic density and breast cancer risk for Japanese women. Breast 17:27-35.
25. Lacroix M, Toillon RA, Leclercq G (2004). Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. Endocr Relat Cancer 11:497-522.
26. Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G (2009). Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 18:479-485.
27. Martin LJ, Boyd NF (2008). Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10:201.
28. Maskarinec G, Meng L (2000). A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat 63:153-161.
29. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN (2005). Mammographic density and breast cancer risk: The multiethnic cohort study. Am J Epidemiol 162:743-752.
30. Mccormack VA, Dowsett M, Folkerd E, Johnson N, Palles C, Coupland B, et al. (2009). Sex steroids, growth factors and mammographic density: A crosssectional study of UK postmenopausal Caucasian and Afro-Caribbean women. Breast Cancer Res 11:R38.
31. Mcshane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2006). REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100:229-235.
32. Nagao Y, Kawaguchi Y, Sugiyama Y, Saji S, Kashiki Y (2003). Relationship between mammographic density and the risk of breast cancer in Japanese women: A case-control study. Breast Cancer 10:228-233.
33. Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, et al. (2005). Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer 92:2102-2106.
34. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. (2000). Molecular portraits of human breast tumours. Nature 406:747-752.
35. Pettersson A, Tamimi RM (2012). Breast fat and breast cancer. Breast Cancer Res Treat 135:321-323.
36. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, et al. (2012). Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 22:340-348.
37. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983). 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303:767-770.
38. Pollan M, Ascunce N, Ederra M, Murillo A, Erdozain N, Ales-Martinez J, et al. (2013). Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: A Spanish population-based case-control study. Breast Cancer Res 15:R9.
39. Rauh C, Gass P, Heusinger K, Haeberle L, Jud SM, Hein A, et al. (2015). Association of molecular subtypes with breast cancer risk factors: A case-only analysis. Eur J Cancer Prev 24:484-490.
40. Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC (2012). Mammographic density and breast cancer risk in White and African American women. Breast Cancer Res Treat 135:571-580.
41. Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC (2013). Association between mammographic density and basal-like and luminal A breast cancer subtypes. Breast Cancer Res 15:R76.
42. Sartor H, Zackrisson S, Elebro K, Hartman L, Borgquist S (2015). Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer. Cancer Causes Control 26:931-939.
43. Song YM, Sung J, Ha M (2008). Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 26:3395-3402.
44. Sorlie T (2004). Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities. Eur J Cancer 40:2667-2675.
45. Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, et al. (2006). Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127.
46. Stingl J, Caldas C (2007). Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7:791-799.
47. Stone J, Ding J, Warren RM, Duffy SW (2010). Predicting breast cancer risk using mammographic density measurements from both mammogram sides and views. Breast Cancer Res Treat 124:551-554.
48. Sung J, Song YM, Stone J (2011). The relationship between bone mineral density and mammographic density in Korean women: The Healthy Twin study. Breast Cancer Res Treat 129:583-591.
49. Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA, et al. (2010). Classical and novel prognostic markers for breast cancer and their clinical significance. Clin Med Insights Oncol 4:15-34.
50. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, et al. (2003). Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332-338.
51. Van De Vijver MJ, He YD, Van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009.
52. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. (2008). Meta-Analysis of gene expression profiles in breast cancer: Toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 10:R65.
53. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, et al. (2011). Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 103:1179-1189.
54. Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, et al. (2008). Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 111:405-410.
55. Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, et al. (2012). Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res 14:R64.
56. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K (2004). Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 13:2090-2095.